Stock Scorer

Aspira Women's Health Inc. (AWHL)

Aspira Women's Health Inc. reported revenue of 2M USD for the quarter ending 30 June 2026, down 14.9% from 2.4M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 2M -14.9%
Gross Profit Q2 '26 · ending 30 June 2026 1.1M -26.3%
Operating Income Q2 '26 · ending 30 June 2026 -1.8M —
Net Income Q2 '26 · ending 30 June 2026 -2.4M —
Cost of Revenue Q2 '26 · ending 30 June 2026 915K +5.2%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -2M —
Free Cash Flow Q4 '25 · ending 31 December 2025 -2M —
Shares Outstanding Q2 '26 · ending 30 June 2026 44.2M +104.9%
EPS Q4 '25 · ending 31 December 2025 -0.36 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 9.2M-7.9M-12.8M-7M
20242024-12-31 9.2M-16.3M-13.1M-12.2M
20232023-12-31 9.2M-18.9M-16.7M-15.9M
20222022-12-31 8.2M-31.1M-29.9M-31.3M
20212021-12-31 6.8M-32.6M-31.7M-27.6M
20202020-12-31 4.7M-18M-17.9M-15.2M
20192019-12-31 4.5M-15.3M-15.2M-13.1M
20182018-12-31 3.1M-11.3M-11.4M-9.5M
20172017-12-31 3.1M-10.4M-10.5M-8.2M
20162016-12-31 2.6M-15M-15M-15.2M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-302M
Q1 '262026-03-312M
Q4 '252025-12-312.2M
Q3 '252025-09-302.3M
Q2 '252025-06-302.4M
Q1 '252025-03-312.3M
Q4 '242024-12-312.3M
Q3 '242024-09-302.3M
Q2 '242024-06-302.4M
Q1 '242024-03-312.2M
Q4 '232023-12-312.1M
Q3 '232023-09-302.2M
Q2 '232023-06-302.5M
Q1 '232023-03-312.3M
Q4 '222022-12-312.2M
Q3 '222022-09-302.1M
Q2 '222022-06-302.1M
Q1 '222022-03-311.9M
Q4 '212021-12-311.9M
Q3 '212021-09-301.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-301.1M
Q1 '262026-03-311.1M
Q4 '252025-12-311.4M
Q3 '252025-09-301.4M
Q2 '252025-06-301.5M
Q1 '252025-03-311.6M
Q4 '242024-12-311.5M
Q3 '242024-09-301.4M
Q2 '242024-06-301.4M
Q1 '242024-03-311.2M
Q4 '232023-12-311.2M
Q3 '232023-09-301.3M
Q2 '232023-06-301.6M
Q1 '232023-03-311.2M
Q4 '222022-12-311.2M
Q3 '222022-09-301.2M
Q2 '222022-06-30966K
Q1 '222022-03-31961K
Q4 '212021-12-311M
Q3 '212021-09-30749K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.8M
Q1 '262026-03-31-2.2M
Q4 '252025-12-31-1.3M
Q3 '252025-09-30-1.6M
Q2 '252025-06-30-1.8M
Q1 '252025-03-31-3.2M
Q4 '242024-12-31-3.4M
Q3 '242024-09-30-3.7M
Q2 '242024-06-30-4.4M
Q1 '242024-03-31-4.7M
Q4 '232023-12-31-4.1M
Q3 '232023-09-30-4.1M
Q2 '232023-06-30-4.3M
Q1 '232023-03-31-6.3M
Q4 '222022-12-31-5.1M
Q3 '222022-09-30-8.6M
Q2 '222022-06-30-8.2M
Q1 '222022-03-31-9.2M
Q4 '212021-12-31-8.9M
Q3 '212021-09-30-9.7M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-2.4M
Q1 '262026-03-31676K
Q4 '252025-12-31-3.4M
Q3 '252025-09-30-4.9M
Q2 '252025-06-30-2.7M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-1.4M
Q3 '242024-09-30-3.5M
Q2 '242024-06-30-3.5M
Q1 '242024-03-31-4.6M
Q4 '232023-12-31-3.1M
Q3 '232023-09-30-4.7M
Q2 '232023-06-30-2.3M
Q1 '232023-03-31-6.6M
Q4 '222022-12-31-4.6M
Q3 '222022-09-30-7.8M
Q2 '222022-06-30-8.2M
Q1 '222022-03-31-9.3M
Q4 '212021-12-31-9M
Q3 '212021-09-30-9.7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30915K
Q1 '262026-03-31896K
Q4 '252025-12-31790K
Q3 '252025-09-30922K
Q2 '252025-06-30870K
Q1 '252025-03-31719K
Q4 '242024-12-31860K
Q3 '242024-09-30902K
Q2 '242024-06-301M
Q1 '242024-03-31939K
Q4 '232023-12-31911K
Q3 '232023-09-30910K
Q2 '232023-06-30941K
Q1 '232023-03-311.1M
Q4 '222022-12-31913K
Q3 '222022-09-30916K
Q2 '222022-06-301.1M
Q1 '222022-03-31932K
Q4 '212021-12-31837K
Q3 '212021-09-30917K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-2M
Q1 '262026-03-31-359K
Q4 '252025-12-31-2M
Q3 '252025-09-30-212K
Q2 '252025-06-30-1.7M
Q1 '252025-03-31-3.1M
Q4 '242024-12-31-1M
Q3 '242024-09-30-2.9M
Q2 '242024-06-30-3.7M
Q1 '242024-03-31-4.4M
Q4 '232023-12-31-3.5M
Q3 '232023-09-303.3M
Q2 '232023-06-303.4M
Q1 '232023-03-31-5.7M
Q4 '222022-12-31-7.1M
Q3 '222022-09-30-7.5M
Q2 '222022-06-30-6.3M
Q1 '222022-03-31-10.2M
Q4 '212021-12-31-7.6M
Q3 '212021-09-30-8M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '252025-12-31-2M
Q4 '242024-12-31-1M
Q3 '242024-09-30-2.9M
Q2 '242024-06-30-3.8M
Q1 '242024-03-31-4.5M
Q4 '232023-12-31-3.5M
Q3 '232023-09-303.3M
Q2 '232023-06-303.4M
Q1 '232023-03-31-5.7M
Q4 '222022-12-31-7.2M
Q3 '222022-09-30-7.6M
Q2 '222022-06-30-6.3M
Q1 '222022-03-31-10.3M
Q4 '212021-12-31-7.7M
Q3 '212021-09-30-8M
Q2 '212021-06-30-6.6M
Q1 '212021-03-31-5.3M
Q4 '202020-12-31-5M
Q3 '202020-09-30-3.2M
Q2 '202020-06-30-3.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3044.2M
Q1 '262026-03-3145.8M
Q3 '252025-09-3036.4M
Q2 '252025-06-3035.6M
Q1 '252025-03-3121.6M
Q3 '242024-09-3015.4M
Q2 '242024-06-3012.5M
Q1 '242024-03-3111.8M
Q3 '232023-09-309.8M
Q2 '232023-06-308.4M
Q1 '232023-03-318.3M
Q3 '222022-09-307.8M
Q2 '222022-06-307.5M
Q1 '222022-03-317.5M
Q3 '212021-09-30112.1M
Q2 '212021-06-30112M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q4 '252025-12-31-0.36
Q3 '252025-09-30-0.34
Q2 '252025-06-30-0.44
Q1 '252025-03-31-0.65
Q4 '242024-12-31-0.95
Q3 '242024-09-30-1.17
Q2 '242024-06-30-1.42
Q1 '242024-03-31-1.42
Q4 '232023-12-31-1.82
Q3 '232023-09-30-2.07
Q2 '232023-06-30-2.59
Q1 '232023-03-31-3.41
Q4 '222022-12-31-3.86
Q3 '222022-09-30-7.41
Q2 '222022-06-30-6.50
Q1 '222022-03-31-5.46
Q4 '212021-12-31-4.27
Q3 '212021-09-30-0.26
Q2 '212021-06-30-0.21
Q1 '212021-03-31-0.19